XML 18 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Net sales $ 2,019,441 $ 2,175,044 $ 2,132,694
Cost of goods sold 897,771 996,527 954,216
Gross profit 1,121,670 1,178,517 1,178,478
Selling, general and administrative expense 761,990 808,200 798,070
Research and development expense 192,972 220,333 210,952
Income from operations 166,708 149,984 169,456
Interest expense 21,692 22,131 61,271
Foreign exchange losses, net 10,249 9,305 8,566
Other (income) expense, net (11,080) (13,009) (12,766)
Income before income taxes 145,847 131,557 112,385
Provision for income taxes (32,754) (42,712) (34,574)
Net income including noncontrolling interests 113,093 88,845 77,811
Net loss (income) attributable to noncontrolling interests 0 0 (21)
Net income attributable to Bio-Rad $ 113,093 $ 88,845 $ 77,790
Basic earnings per share:      
Net income per share basic attributable to Bio-Rad $ 3.87 $ 3.08 $ 2.72
Weighted average common shares - basic 29,186 28,876 28,586
Diluted earnings per share:      
Net income per share diluted attributable to Bio-Rad $ 3.85 $ 3.05 $ 2.69
Weighted average common shares - diluted 29,409 29,133 28,906